The Treatment experience,burden,and unmet needs (TRIBUNE) study – measuring the socioeconomic consequences of Multiple Sclerosis

Abstract

Get full access to this article

View all access options for this article.

References

Dutta

Trapp

. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol 2011; 93: 1–12.

Hauser

Oksenberg

. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006; 52: 61–76.

Poser

. Multiple sclerosis trait: the premorbid stage of multiple sclerosis. A hypothesis. Acta Neurol Scand 2004; 109: 239–243.

Pugliatti

Rosati

Carton

. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006; 13: 700–722.

Sadovnick

. European Charcot Foundation Lecture: the natural history of multiple sclerosis and gender. J Neurol Sci 2009; 286: 1–5.

Gustavsson

Svensson

Jacobi

. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 718–779.

Olesen

Gustavsson

Svensson

Wittchen

Jonsson

. The economic cost of brain disorders in Europe. Eur J Neurol 2012; 19: 155–162.

Kobelt

Berg

Lindgren

Fredrikson

Jonsson

. Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry 2006; 77: 918–926.

Karampampa

Gustavsson

Miltenburger

Eckert

. Treatment Experience, Burden, and Unmet Needs (TRIBUNE) in MS study: results from five European countries. Multiple Sclerosis Journal 2012; publication in print.

10.

Sorenson

Chalkidou

. Reflections on the evolution of health technology assessment in Europe. Health Econ Policy Law 2012; 7: 25–45.